Testing a new drug to prevent Alzheimer's disease and dementia

目的

Do any of your friends, family, or loved ones have problems remembering or have developed Alzheimer’s disease? The USC Alzheimer Disease Research Center is testing how well a drug may help to prevent the loss of memory. The research team is looking for volunteers (ages 60 to 75) who do not have signs of cognitive problems (meaning that their speech, thinking, and memory are fine compared to other people of the same age).

If you're eligible and choose to take part, you'll be one of the few people that can join the fight against Alzheimer's disease. But preventing such a disease won't happen overnight. The trial will run for between 5 and 8 years.

Participation is at no cost. USC will pay for all of the related medical expenses including transportation.

关键词: Alzheimer's Disease, Mild Cognitive Impairment, dementia, APOE4 genotype

研究地点

USC Keck Hospital, 1520 San Pablo Street 90033

 
  • Men & Women
Age icon
60 - 75
 
 
要么
 

涉及什么?

学习篇幅
  • 5 years and 3 years of follow-up

访问次数
  • 21 visits and 11 for follow-up

处方
  • CNP520 or placebo

程序
  • Brain imaging

  • Heart activity measurement

  • Blood sample

  • Memory testing

Compensation
  • There will be no payment for your participation.

医疗费用保险
  • USC will pay for all of the related medical expenses including transportation.

Why participate?

If you're the grandparent who spends time with their grandchildren, be the one who helps protect them from Alzheimer's disease.

New study tests drug against #memory loss. Volunteers ages 60 to 75 are welcome to join. Be the one who helps protect future generations from #Alzheimer's disease. Join today!

合格

一定有


  • Ages 60 to 75
  • People who do not have signs of cognitive problems (meaning that their speech, thinking, and memory are fine compared to other people of the same age).
  • Must speak and understand English or Spanish

About This Study

This research study is sponsored by Novartis, in collaboration with another pharmaceutical company named Amgen and in partnership with Banner Alzheimer’s Institute. Novartis produces the drug and provides funding to cover the costs of conducting this research study.

ClinicalTrials.gov Identifier: NCT03131453


Some of the potential benefits of being a participant in this clinical research study include:
• Having access to expert medical care for AD during the study and regular monitoring for clinical symptoms of AD, and regular health checks and health information
• Helping others with elevated risk for AD clinical symptoms by contributing to medical research
• Gaining access to new research treatments
• Getting actively involved in your health care

Study Team

Photohandler
Principal Investigator
Lon Schneider, MD

For questions about this study, contact:

  • Project Director Karen Dagerman
  • University of Southern California Keck School of Medicine
  • 323-442-7600
  • adrc@med.usc.edu
  • Clinical Trials Manager Mauricio Becerra
  • University of Southern California Keck School of Medicine
  • 323-442-7594
  • mjbecerr@usc.edu

We respect your privacy!

All the information you give us is stored in a secure, password protected database. All the information that you choose to share will be kept private and confidential. Read University of Southern California's Privacy Policy here.